TYRA Insider Trading

Insider Ownership Percentage: 18.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $1,486,260.86

Tyra Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Tyra Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Tyra Biosciences Share Price & Price History

Current Price: $15.11
Price Change: Price Decrease of -0.89 (-5.56%)
As of 04/25/2024 01:00 AM ET

This chart shows the closing price history over time for TYRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Tyra Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2024Daniel BensenCOOSell200$20.00$4,000.00431,683View SEC Filing Icon  
3/6/2024Daniel BensenCOOSell1,733$20.09$34,815.97431,951View SEC Filing Icon  
2/29/2024Daniel BensenCOOSell2,050$20.00$41,000.00442,836View SEC Filing Icon  
2/27/2024Daniel BensenCOOSell745$20.00$14,900.00450,735View SEC Filing Icon  
2/12/2024Daniel BensenCOOSell1,501$20.00$30,020.00451,480View SEC Filing Icon  
2/7/2024Daniel BensenCOOSell9,587$18.09$173,428.83452,981View SEC Filing Icon  
7/21/2023Daniel BensenCOOSell3,900$16.01$62,439.00527,981View SEC Filing Icon  
7/19/2023Daniel BensenCOOSell207$16.07$3,326.49527,981View SEC Filing Icon  
7/17/2023Daniel BensenCOOSell1,900$16.03$30,457.00527,981View SEC Filing Icon  
7/13/2023Daniel BensenCOOSell500$16.13$8,065.00527,981View SEC Filing Icon  
7/11/2023Daniel BensenCOOSell500$16.02$8,010.00527,981View SEC Filing Icon  
7/3/2023Daniel BensenCOOSell4,265$16.37$69,818.05527,981View SEC Filing Icon  
6/30/2023Daniel BensenCOOSell18,819$16.97$319,358.43527,981View SEC Filing Icon  
6/27/2023Daniel BensenCOOSell16,028$16.91$271,033.48527,981View SEC Filing Icon  
6/22/2023Todd HarrisCEOSell3,478$17.04$59,265.121,621,988View SEC Filing Icon  
6/20/2023Todd HarrisCEOSell1,300$16.53$21,489.001,645,222View SEC Filing Icon  
6/15/2023Todd HarrisCEOSell12,773$16.13$206,028.491,701,276View SEC Filing Icon  
6/14/2023Daniel BensenCOOSell120$16.45$1,974.00527,981View SEC Filing Icon  
6/13/2023Todd HarrisCEOSell7,927$16.00$126,832.001,701,276View SEC Filing Icon  
4/3/2023Daniel BensenCOOSell2,000$16.16$32,320.00527,981View SEC Filing Icon  
3/31/2023Daniel BensenCOOSell400$16.00$6,400.00527,981View SEC Filing Icon  
3/30/2023Todd HarrisCEOSell2,407$16.02$38,560.141,701,276View SEC Filing Icon  
3/29/2023Daniel BensenCOOSell2,187$16.21$35,451.27527,981View SEC Filing Icon  
3/28/2023Todd HarrisCEOSell2,779$16.00$44,464.001,701,276View SEC Filing Icon  
3/27/2023Daniel BensenCOOSell8,048$16.00$128,768.00527,981View SEC Filing Icon  
3/24/2023Todd HarrisCEOSell170$16.00$2,720.001,701,276View SEC Filing Icon  
3/22/2023Daniel BensenCOOSell3,800$16.00$60,800.00527,981View SEC Filing Icon  
3/22/2023Todd HarrisCEOSell4,043$16.00$64,688.001,701,276View SEC Filing Icon  
2/9/2023Mva Investors, LlcMajor ShareholderSell200,000$13.10$2,620,000.0088,095View SEC Filing Icon  
12/17/2021Boxer Capital, LlcMajor ShareholderBuy125,000$13.12$1,640,000.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Tyra Biosciences (NASDAQ:TYRA)

84.14% of Tyra Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at TYRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Tyra Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024Fishman Jay A Ltd. MI15,000$0.25M0.0%N/A0.029%Search for SEC Filing on Google Icon
3/5/2024Wellington Management Group LLP102,436$1.42M0.0%+8.8%0.238%Search for SEC Filing on Google Icon
2/15/2024Frazier Life Sciences Management L.P.1,026,420$14.22M0.8%-0.2%2.384%Search for SEC Filing on Google Icon
2/14/2024Artia Global Partners LP10,253$0.14M0.0%-77.3%0.024%Search for SEC Filing on Google Icon
2/14/2024Kynam Capital Management LP340,190$4.71M0.5%N/A0.790%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC4,235$59K0.1%N/A0.010%Search for SEC Filing on Google Icon
2/5/2024Victory Capital Management Inc.50,220$0.70M0.0%+53.4%0.117%Search for SEC Filing on Google Icon
1/31/2024Federated Hermes Inc.2,070$29K0.0%+1,244.2%0.005%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC9,531$0.13M0.0%+34.0%0.022%Search for SEC Filing on Google Icon
12/1/2023Wellington Management Group LLP94,112$1.30M0.0%+18.5%0.219%Search for SEC Filing on Google Icon
11/14/2023Corton Capital Inc.11,009$0.15M0.1%N/A0.026%Search for SEC Filing on Google Icon
11/13/2023FMR LLC3,898,827$53.69M0.0%-5.3%9.054%Search for SEC Filing on Google Icon
11/1/2023Simplex Trading LLC2,009$27K0.0%+198.1%0.005%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp41,870$0.58M0.0%+2.6%0.097%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC7,114$98K0.0%-19.8%0.017%Search for SEC Filing on Google Icon
9/21/2023Barclays PLC2,788$48K0.0%-58.9%0.006%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC360,000$6.13M0.2%-27.2%0.837%Search for SEC Filing on Google Icon
8/15/2023BVF Inc. IL2,739,595$46.66M1.3%-15.4%6.370%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC150,468$2.56M0.0%+12.1%0.350%Search for SEC Filing on Google Icon
7/24/2023Allspring Global Investments Holdings LLC2,273$39K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC8,867$0.15M0.0%N/A0.021%Search for SEC Filing on Google Icon
7/18/2023Allspring Global Investments Holdings LLC2,273$39K0.0%N/A0.005%Search for SEC Filing on Google Icon
7/7/2023Auour Investments LLC85,020$1.45M0.6%N/A0.200%Search for SEC Filing on Google Icon
5/16/2023BVF Inc. IL3,239,595$52.06M1.9%+31.0%7.611%Search for SEC Filing on Google Icon
5/15/2023Logos Global Management LP87,673$1.41M0.2%-20.9%0.206%Search for SEC Filing on Google Icon
5/11/2023FMR LLC3,147,987$50.59M0.0%-18.8%7.397%Search for SEC Filing on Google Icon
5/2/2023Victory Capital Management Inc.33,760$0.54M0.0%N/A0.079%Search for SEC Filing on Google Icon
11/15/2022TCG Crossover Management LLC945,707$8.31M2.5%+5.5%2.241%Search for SEC Filing on Google Icon
11/15/2022Logos Global Management LP127,316$1.12M0.1%-23.5%0.302%Search for SEC Filing on Google Icon
10/28/2022Sepio Capital LP10,625$93K0.0%N/A0.025%Search for SEC Filing on Google Icon
10/26/2022Fishman Jay A Ltd. MI10,500$92K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP289,172$2.07M0.0%+8.6%0.692%Search for SEC Filing on Google Icon
8/15/2022Sio Capital Management LLC152,159$1.09M0.4%+37.0%0.364%Search for SEC Filing on Google Icon
8/10/2022Frazier Life Sciences Management L.P.1,375,065$9.83M0.9%+3.6%3.293%Search for SEC Filing on Google Icon
7/27/2022Bailard Inc.12,910$92K0.0%N/A0.031%Search for SEC Filing on Google Icon
5/17/2022Fairmount Funds Management LLC1,284,990$13.75M3.3%+99.1%3.077%Search for SEC Filing on Google Icon
5/16/2022Frazier Life Sciences Management L.P.1,327,665$14.21M1.2%N/A3.179%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund10,517$0.11M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP264,745$3.73M0.1%-27.7%0.642%Search for SEC Filing on Google Icon
2/18/2022TCG Crossover Management LLC850,450$11.97M5.6%N/A2.061%Search for SEC Filing on Google Icon
2/14/2022Boxer Capital LLC6,448,359$90.73M3.5%+2.0%15.626%Search for SEC Filing on Google Icon
2/14/2022Perceptive Advisors LLC673,352$9.47M0.1%-31.8%1.632%Search for SEC Filing on Google Icon
2/14/2022Nextech Invest AG2,518,582$35.44M8.2%N/A6.103%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp103,493$1.46M0.0%N/A0.251%Search for SEC Filing on Google Icon
2/3/2022Canaan Partners XI LLC4,409,991$62.05M16.0%N/A10.687%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio2,800$39K0.0%N/A0.007%Search for SEC Filing on Google Icon
12/3/2021Perceptive Advisors LLC987,500$17.37M0.2%N/A2.393%Search for SEC Filing on Google Icon
11/16/2021Janus Henderson Group PLC1,374,648$22.84M0.0%N/A3.331%Search for SEC Filing on Google Icon
11/16/2021Wellington Management Group LLP695,371$12.23M0.0%N/A1.685%Search for SEC Filing on Google Icon
11/16/2021BVF Inc. IL1,694,933$29.81M1.2%N/A4.107%Search for SEC Filing on Google Icon
11/16/2021Boxer Capital LLC6,323,359$111.23M3.9%N/A15.323%Search for SEC Filing on Google Icon
11/15/2021Deerfield Management Company L.P. Series C625,000$10.99M0.2%N/A1.515%Search for SEC Filing on Google Icon
11/15/2021RA Capital Management L.P.7,236,454$127.29M1.8%N/A17.536%Search for SEC Filing on Google Icon
11/15/2021Ensign Peak Advisors Inc125,000$2.20M0.0%N/A0.303%Search for SEC Filing on Google Icon
11/10/2021Goldman Sachs Group Inc.207,283$3.65M0.0%N/A0.502%Search for SEC Filing on Google Icon
11/9/2021Jennison Associates LLC468,750$8.25M0.0%N/A1.136%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Tyra Biosciences logo
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in Phase 1/2 clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in Phase 1 clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Read More on Tyra Biosciences

Today's Range

Now: $15.11
Low: $14.79
High: $16.15

50 Day Range

MA: $17.53
Low: $14.45
High: $20.00

52 Week Range

Now: $15.11
Low: $10.38
High: $20.67

Volume

137,545 shs

Average Volume

123,151 shs

Market Capitalization

$793.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of Tyra Biosciences?

Tyra Biosciences' top insider investors include:
  1. Todd Harris (CEO)
  2. Daniel Bensen (COO)
  3. Mva Investors, Llc (Major Shareholder)
Learn More about top insider investors at Tyra Biosciences.

Who are the major institutional investors of Tyra Biosciences?

Tyra Biosciences' top institutional investors include:
  1. Fishman Jay A Ltd. MI — 0.03%
Learn More about top institutional investors of Tyra Biosciences stock.

Which institutional investors are buying Tyra Biosciences stock?

In the previous quarter, TYRA stock was purchased by institutional investors including:
  1. Fishman Jay A Ltd. MI